跳至主要内容
临床试验/NCT00420264
NCT00420264已完成不适用

Feasibility of Using Gynecare Thermachoice III in the Office Setting Without Conscious Sedation

Female Pelvic Medicine & Urogynecology Institute of Michigan2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2005年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21
试验地点
2
主要终点
Tolerability of Uterine Ablation in the office setting

研究概览

简要总结

Investigational study to determine if an endometrial ablation for heavy uterine bleeding, can be tolerated in the office setting without the use of intravenous medication.

详细描述

A safe and effective treatment , called endometrial ablation, has been used in a hospital setting under general anesthesia for the treatment of heavy uterine bleeding. This study will evaluate if patients would tolerate the same procedure in an office setting using local anesthetics and common pain medication. This study will include twenty patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Heavy uterine bleeding

排除标准

  • Uterine or cervical cancer
  • Unable to tolerate office hysteroscopy
  • Uterine fibroid tumors that distort endometrial cavity
  • Uterine cavity greater than 12 cm
  • Patients with hyperplasia or premalignant changes of the endometrium
  • Active genital or urinary tract infections
  • Intrauterine device
  • Pregnant or want to become pregnant

结局指标

主要结局

Tolerability of Uterine Ablation in the office setting

时间窗: 30 days

次要结局

未报告次要终点

研究者

发起方
Female Pelvic Medicine & Urogynecology Institute of Michigan
申办方类型
Other

研究点 (2)

Loading locations...

相似试验